Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study

BACKGROUND/AIMS: Prognostic models are lacking for patients with recurrent hepatocellular carcinoma (HCC) following surgical resection. This study devised and validated a new hepatoma arterial-embolization prognostic (HAP) score optimized for use in patients undergoing treatment with transarterial c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Mi Young, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Yoon Jun, Yoon, Jung-Hwan, Cho, Eun Ju, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366139/
https://www.ncbi.nlm.nih.gov/pubmed/31640304
http://dx.doi.org/10.5009/gnl19111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366139/
https://www.ncbi.nlm.nih.gov/pubmed/31640304
http://dx.doi.org/10.5009/gnl19111

Ejemplares similares